How are Life Sciences M&A deals faring in a volatile macroeconomic climate?
The team at SRS Acquiom recently interviewed industry experts to learn more about the current state of Life Sciences M&A. In this article, we cover experts’ views on the pace of deals, regulatory impacts, and thoughts on what’s next for Life Sciences M&A. Inform your next negotiation with new perspectives:
- What’s weighing on Life Sciences M&A
- Who the buyers are
- Issues that matter when structuring deals and earnouts
- Information rights
- Impact of RWI
- And more
Gain fresh insights on life sciences M&A deals and put them to use on your next transaction.
Download the article below.